Kronos Bio Inc (KRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,393 | 49,733 | 42,509 | 44,558 | 56,466 |
| Marketable Securities | 66,531 | 46,474 | 44,431 | 22,118 | 12,207 |
| Receivables | 83,111 | 73,480 | 83,287 | 75,084 | 71,716 |
| Income taxes - deferred | 10,086 | 8,818 | 8,427 | 8,327 | 7,397 |
| Other current assets | 18,605 | 19,076 | 18,649 | 19,165 | 18,960 |
| TOTAL | $215,726 | $197,581 | $197,303 | $169,252 | $166,746 |
| Non-Current Assets | |||||
| PPE Net | 39,593 | 39,491 | 39,263 | 39,261 | 39,537 |
| Investments And Advances | 46,566 | 48,771 | 44,065 | 36,401 | 25,347 |
| Intangibles | 94,536 | 95,314 | 93,384 | 93,439 | 90,960 |
| Other Non-Current Assets | 39,376 | 37,872 | 37,803 | 33,931 | 33,339 |
| TOTAL | $220,071 | $221,448 | $214,515 | $203,032 | $189,183 |
| Total Assets | $435,797 | $419,029 | $411,818 | $372,284 | $355,929 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,450 | 6,275 | 6,584 | 6,550 | 7,692 |
| Accrued Expenses | 37,794 | 41,190 | 51,824 | 41,036 | 40,651 |
| TOTAL | $168,545 | $164,577 | $176,057 | $159,971 | $159,471 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 123,301 | 117,112 | 117,649 | 112,385 | 111,128 |
| Other Non-Current Liabilities | 3,650 | 3,792 | 3,655 | 3,808 | 3,765 |
| TOTAL | $18,994 | $19,432 | $19,164 | $17,301 | $17,206 |
| Total Liabilities | $187,539 | $184,009 | $195,221 | $177,272 | $176,677 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,050 | 30,909 | 30,751 | 30,266 | 29,701 |
| Common Shares | 311 | 309 | 304 | 200 | 199 |
| Retained earnings | 194,873 | 185,253 | 177,841 | 165,870 | 157,486 |
| Other shareholders' equity | 1,590 | 1,123 | 348 | -142 | -1,176 |
| TOTAL | $248,258 | $235,020 | $216,597 | $195,012 | $179,252 |
| Total Liabilities And Equity | $435,797 | $419,029 | $411,818 | $372,284 | $355,929 |